NCT07310992

Brief Summary

Cardiovascular rehabilitation is a well-established standard of care that significantly reduces morbidity and mortality while improving quality of life. However, integrating behavioral interventions into physical training may offer additional benefits for autonomic regulation and emotional well-being. This randomized clinical trial aims to investigate the efficacy of adding a brief, guided mindfulness meditation session to a standard cardiovascular rehabilitation program. The study seeks to determine whether this combined intervention enhances blood pressure control, improves perceived quality of life, and increases patient adherence compared to standard rehabilitation alone. Participants newly enrolled in the Cardiac Rehabilitation Service will be randomized into two groups. Both groups will undergo a standard 12-week regimen of aerobic and resistance training combined with optimized medical therapy. The intervention group will additionally receive 15 minutes of voice-guided mindfulness meditation at the end of each exercise session. Key outcome measures include blood pressure variability, quality of life scores (assessed via EQ-5D), and attendance rates.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
19mo left

Started Jan 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Jan 2026Jan 2028

First Submitted

Initial submission to the registry

December 16, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 30, 2025

Completed
16 days until next milestone

Study Start

First participant enrolled

January 15, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2028

Last Updated

January 5, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

December 16, 2025

Last Update Submit

December 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of Life Scores (EuroQol EQ-5D Visual Analogue Scale)

    Quality of life is assessed using the EuroQol Five Dimensions Questionnaire (EQ-5D). This instrument includes the EQ Visual Analogue Scale (EQ-VAS), a quantitative measure of the participant's self-rated health status. The EQ-VAS scores range from a minimum of 0 to a maximum of 100, where 0 represents 'the worst health you can imagine' and 100 represents 'the best health you can imagine'. Higher scores indicate better health outcomes and higher quality of life.

    Baseline and Week 12

Secondary Outcomes (2)

  • Change in Systolic and Diastolic Blood Pressure

    Baseline and Week 12

  • Rate of Rehabilitation Adherence

    Through study completion, an average of 12 weeks

Study Arms (2)

Experimental: Meditation + Rehabilitation

EXPERIMENTAL

Participants in this group will undergo the standard cardiac rehabilitation program consisting of 60 minutes of aerobic and resistance training, twice a week for 12 weeks. Additionally, they will participate in a 15-minute voice-guided mindfulness meditation session immediately following each exercise session. Participants also receive optimized medical therapy.

Behavioral: Meditation

Active Comparator: Standard Rehabilitation

ACTIVE COMPARATOR

Participants in this group will undergo the standard cardiac rehabilitation program consisting of 60 minutes of aerobic and resistance training, twice a week for 12 weeks, along with optimized medical therapy. This group does not receive the guided meditation intervention.

Procedure: Standard Cardiac Rehabilitation

Interventions

MeditationBEHAVIORAL

Participants in this group will undergo the standard cardiac rehabilitation program consisting of 60 minutes of aerobic and resistance training, twice a week for 12 weeks. Additionally, they will participate in a 15-minute voice-guided mindfulness meditation session immediately following each exercise session. Participants also receive optimized medical therapy.

Experimental: Meditation + Rehabilitation

Participants in this group will undergo the standard cardiac rehabilitation program consisting of 60 minutes of aerobic and resistance training, twice a week for 12 weeks, along with optimized medical therapy. This group does not receive the guided meditation intervention.

Active Comparator: Standard Rehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of both sexes, aged 18 years or older.
  • Newly enrolled in the Phase II Cardiac Rehabilitation Program.
  • Clinically stable condition with medical clearance to perform aerobic and resistance exercises.
  • Diagnosis of cardiovascular disease (e.g., coronary artery disease, post-myocardial infarction, post-cardiac surgery, or stable heart failure) warranting rehabilitation.
  • Willingness and cognitive ability to provide written informed consent.
  • Availability to attend the twice-weekly sessions for the 12-week duration of the study.

You may not qualify if:

  • Current regular practice of meditation, yoga, or other mind-body techniques (defined as formal practice more than once a week in the previous 3 months).
  • Current participation in other psychological or behavioral intervention clinical trials.
  • Severe cognitive impairment or psychiatric disorders that preclude understanding of the meditation instructions or group participation (e.g., dementia, untreated psychosis).
  • Unstable clinical conditions such as unstable angina, uncontrolled arrhythmias, or decompensated heart failure that contraindicate physical exercise.
  • Significant orthopedic or neurological limitations that prevent the performance of the exercise protocol.
  • Refusal to participate in the randomization process.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

HypertensionEssential Hypertension

Interventions

Meditation

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Arm 1 - Control Group Name: Standard Cardiac Rehabilitation Description: Participants undergo 60 minutes of aerobic and resistance training, twice per week, for 12 weeks, with optimized medical therapy. Intervention Type: Behavioral / Exercise Duration: 12 weeks Arm 2 - Meditation Group (Intervention Group) Name: Cardiac Rehabilitation + Meditation Description: Participants undergo 60 minutes of aerobic and resistance training + 15 minutes of guided mindfulness meditation at the end of each session, twice per week, for 12 weeks, with optimized medical therapy. Intervention Type: Behavioral / Meditation (Mindfulness) Duration: 12 weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Guacira Grecca

Study Record Dates

First Submitted

December 16, 2025

First Posted

December 30, 2025

Study Start

January 15, 2026

Primary Completion (Estimated)

January 15, 2027

Study Completion (Estimated)

January 15, 2028

Last Updated

January 5, 2026

Record last verified: 2025-12